ORIGINAL ARTICLESSafety of inhaled corticosteroid therapy in young children with asthma
REFERENCES (26)
- et al.
Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
Respir Med
(1994) - et al.
Short-term growth in asthmatic children using fluticasone propionate
Chest
(1998) - et al.
Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide
J Pediatr
(1999) - et al.
Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group
J Pediatr
(1998) - et al.
Growth and the growth hormone axis in prepubertal children with asthma
J Pediatr
(1995) - et al.
Growth and adrenal responsiveness with budesonide in young asthmatics
Respir Med
(1994) - et al.
Safety of 1 year of treatment with budesonide in young children with asthma
J Allergy Clin Immunol
(1990) Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
(1997)- et al.
Inhaled corticosteroid prescribing in very young children
J Allergy Clin Immunol
(1997) - et al.
Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study
Eur Respir J
(1997)
Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma
Pediatr Pulmonol
An open study to assess the safety and efficacy of fluticasone propionate in preschool asthmatic children
Allergy
Büyüme ve gelisme bozukluklan
Cited by (13)
Inhaled corticosteroids in asthma: Which tolerance in 2009?
2010, Archives de PediatrieMaternal positive skin prick test results and asthma prediction after early childhood wheezing
2007, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :For children who develop asthma in infancy, early intervention may still be beneficial. Treating all wheezing infants with a medicine regularly may expose them to a variety of adverse effects and carry a tremendous burden, both psychological and financial.3-8 Therefore, it would be desirable to establish criteria to distinguish the subgroup of infants with wheezing who will develop asthma later in life.
Fluticasone propionate in children and infants with asthma
2007, Archives de PediatrieFluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control
2005, ChestCitation Excerpt :Perhaps more importantly, 24-h urinary cortisol excretion concentrations at baseline (ie, at a time when > 68% of patients across the groups were not receiving an ICS) and after 4 weeks of treatment with either FPANS plus FSC, montelukast plus FSC, or placebo plus FSC were comparable, and there was no evidence of a differential effect among the three treatment groups. The lack of effect of fluticasone propionate on hypothalamic-pituitary-adrenal axis function in this study, as assessed by 24-h urinary cortisol excretion, is consistent with previous studies.2526272829 Despite the strong evidence for an immunologically integrated “one airway,” this study suggests that the applicability of this hypothesis to clinical treatment of rhinitis and asthma may be limited.
Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis
2016, Allergy and Asthma ProceedingsNo effect of fluticasone propionate on linear growth in preschool children with asthma
2011, Pediatrics International